HSD17B10 and myeloid sarcoma: The presence of augmented levels of Parkin in CSF levels was recently confirmed by Kristofikova and colleagues, who found increased levels of the kinase bound to the mitochondrial protein 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10) in CSF of MS-affected patients [36].